KB
Kostas Biliouris Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
18
Avg Return
Past Year
Past Year
24%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
60%
Neutral
40%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $62 |
181%
upside
| 1 | -23% |
0
%
| 10 Dec ‘25 29 days ago |
|
|
|
Outperform
Upgraded
| $50 |
116%
upside
| 5 | +33% |
0
%
| 22 Sep ‘25 3 months ago |
|
|
|
Market Perform
Downgraded
| $48 | – | 1 | – |
–
| 15 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $470 |
18%
upside
| 2 | +16% |
0
%
| 8 Sep ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $70 |
14%
downside
| 2 | +42% |
0
%
| 3 Sep ‘25 4 months ago |
|
|
|
Market Perform
Downgraded
| $4 |
141%
upside
| 1 | – |
–
| 8 Jul ‘25 6 months ago |
|
|
|
Market Perform
Downgraded
| $13.50 |
21%
upside
| 1 | – |
–
| 27 Jun ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $8 |
106%
upside
| 2 | -2.5% |
0
%
| 28 May ‘25 7 months ago |
|
|
|
Outperform
Initiated
| $72 |
1%
downside
| 1 | +145% |
0
%
| 12 Mar ‘25 10 months ago |
|
|
|
Outperform
Initiated
| $50 |
174%
upside
| 1 | +52% |
0
%
| 12 Mar ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $25 |
331%
upside
| 1 | +34% |
0
%
| 4 Mar ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $50 |
375%
upside
| 1 | -12% |
0
%
| 10 Jan ‘25 1 year ago |
|
|
|
Outperform
Upgraded
| $34 |
744%
upside
| 1 | -10% |
0
%
| 10 Jan ‘25 1 year ago |
|